Clinical Trials Logo

Clinical Trial Summary

This study represents a prospective, non-randomized, dual-center clinical study to evaluate the safety and effectiveness of the CapBuster System in crossing a de novo or restenotic infrapopliteal chronic total occlusion. Measures of safety and efficacy will be assessed through 30 days post-intervention.


Clinical Trial Description

The diagnostic and interventional procedure can be conducted via contralateral or antegrade approach and arterial access will be obtained utilizing standard percutaneous techniques and devices. Baseline angiographic images will be obtained prior to the study intervention to confirm the presence of a peripheral arterial occlusion. These images will include the target lesion as well as inflow and outflow with ipsilateral run off to the distal foot. If angiographic imaging confirms that the subject meets enrollment criteria, the enrolled subject will then undergo the study procedure. If the investigator determines that treatment is required of non-target arterial lesions, the treatment may be performed during the study index procedure according to the investigator's standard practices using commercially available devices. Prior to utilization of the CapBuster system, the investigator will attempt to cross the target lesion CTO utilizing conventional catheters and guidewires. To minimize vessel trauma, attempted guidewire crossing time will be limited to no more than 5 minutes. The crossing time will begin when the guidewire reaches the lesion CTO cap and will end after occlusion is successfully crossed with confirmed wire placement in the true lumen. If successful crossing is achieved with a conventional guidewire, the CapBuster system will not be utilized. The subject will be a screen failure and will not be considered enrolled in the trial. If crossing attempt is not successful with a conventional guidewire, the CapBuster system will be utilized. A subject is considered enrolled in the study upon introduction of the CapBuster system into the subject's vasculature. The CapBuster support catheter will be inserted over a conventional guidewire and advanced until the distal tip reaches the CTO cap. The CapBuster 3.0 mm diameter balloon is then inflated to stabilize the system within the arterial vessel. The conventional guidewire is replaced with the CapBuster penetrating wire and, under fluoroscopic guidance, the penetrating wire is manually rotated to penetrate the CTO cap. The balloon pressure may be increased to ensure proper apposition with the vessel wall and maximize stability. Following penetration of the cap, the penetrating wire is replaced with a conventional steerable guidewire. Standard wire escalation techniques will be utilized for continued advancement of the conventional guidewire and complete crossing of the occlusion. Angiography is performed to confirm guidewire placement. Successful crossing is defined as guidewire placement within the true lumen proximal and distal to the target lesion without utilization of a re-entry device. After successful crossing is achieved, the target lesion may be treated per Investigator discretion with commercially available devices. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04710342
Study type Interventional
Source Praxis Medical Devices Ltd
Contact Brendan McLaughlin
Phone 353872471662
Email brendanmclaughlin1@gmail.com
Status Recruiting
Phase N/A
Start date June 21, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05111496 - Evaluation of the Radiological Dose Delivered to Risky Interventional Cardiology Patients (Optidose)
Not yet recruiting NCT05440084 - Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity
Withdrawn NCT04059536 - Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)
Completed NCT05158686 - Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty
Completed NCT03988166 - Chronic Total Occlusion Percutaneous Coronary Intervention Study N/A
Not yet recruiting NCT06175377 - Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery N/A
Not yet recruiting NCT05632653 - CTO-PCI in Heart Failure Patients N/A
Recruiting NCT03563989 - STENTYS Xposition S in the Treatment of Chronic Total Artery Occlusion N/A
Not yet recruiting NCT06358508 - Sapphire 3 CTO Study N/A
Completed NCT01246505 - Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions Phase 3
Recruiting NCT05614180 - Chronic Total Occlusive Lesions CMR Study
Completed NCT04226326 - Investigating the Utility of Remote Index of Microvascular Resistance in Patients With Chronic Total Occlusion N/A
Recruiting NCT04533633 - German Epicardial Collateral CTO Registry
Recruiting NCT04650139 - Coronary Interventions Ulm - Coronary Chronic Total Occlusions
Recruiting NCT06137521 - Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Completed NCT02358629 - A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO). N/A
Completed NCT00670436 - The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions Phase 2
Completed NCT04862559 - A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions N/A
Active, not recruiting NCT02227771 - Consistent CTO Trial N/A
Recruiting NCT05458999 - Decreasing Patient Anxiety During Revascularization of Chronic Total Coronary Occlusions Using Virtual Reality Glasses. N/A